$1B+ HK listing positions Jiangsu Hengrui to broaden global innovation push

Look for shares of Jiangsu Hengrui to begin trading in Hong Kong on Friday as the company aims to tap a broader pool of investors to complement its stature as a Chinese innovator with a global presence.

Jiangsu Hengrui Pharmaceuticals Co. Ltd. (Shanghai:600276; HKEX:1276) raised HK$9.9 billion (US$1.3 billion) in a follow-on offering on the Stock Exchange of Hong Kong via the sale of shares at HK$44.05. The deal gives the company a valuation of HK$352.5 billion, or US$45 billion...